OBJECTIVE: To evaluate the hemodynamic characteristics of metabolic syndrome (MetS) in the absence and presence of hypertension. MATERIALS/ METHODS: Altogether 166 subjects without previously diagnosed cardiovascular disease, diabetes, or antihypertensive medication, were allocated to four groups: control, hypertension only, MetS without hypertension, and MetS with hypertension (mean age 44-46 years). Cut-point for hypertension was blood pressure ≥140/90 mmHg. Other criteria of MetS were as defined by Alberti et al. 2009. Hemodynamic variables were measured using whole-body impedance cardiography and pulse wave analysis. RESULTS: Pulse wave velocity was higher in hypertensive and normotensive subjects with MetS than controls (p<0.05), and in the hypertensive MetS group than subjects with hypertension only (p<0.05). Aortic pulse pressure was higher in the two hypertensive groups than the two normotensive groups (p<0.05). Systemic vascular resistance index was higher in the hypertensive than normotensive MetS group (p<0.05), and in the group with hypertension alone than in controls (p<0.05). Heart rate was higher in the hypertensive Mets group than in controls and subjects with hypertension only (p<0.05). Cardiac index did not differ, while stroke index was lower in both groups with MetS than groups without MetS. Augmentation pressure was higher in the hypertensive MetS group than in controls and normotensive MetS group (p<0.05). CONCLUSIONS: Pulse wave velocity, an acknowledged marker of arterial stiffness, was associated with MetS even in the absence of hypertension. This emphasizes the importance of the prevention and treatment of MetS.
OBJECTIVE: To evaluate the hemodynamic characteristics of metabolic syndrome (MetS) in the absence and presence of hypertension. MATERIALS/ METHODS: Altogether 166 subjects without previously diagnosed cardiovascular disease, diabetes, or antihypertensive medication, were allocated to four groups: control, hypertension only, MetS without hypertension, and MetS with hypertension (mean age 44-46 years). Cut-point for hypertension was blood pressure ≥140/90 mmHg. Other criteria of MetS were as defined by Alberti et al. 2009. Hemodynamic variables were measured using whole-body impedance cardiography and pulse wave analysis. RESULTS: Pulse wave velocity was higher in hypertensive and normotensive subjects with MetS than controls (p<0.05), and in the hypertensive MetS group than subjects with hypertension only (p<0.05). Aortic pulse pressure was higher in the two hypertensive groups than the two normotensive groups (p<0.05). Systemic vascular resistance index was higher in the hypertensive than normotensive MetS group (p<0.05), and in the group with hypertension alone than in controls (p<0.05). Heart rate was higher in the hypertensive Mets group than in controls and subjects with hypertension only (p<0.05). Cardiac index did not differ, while stroke index was lower in both groups with MetS than groups without MetS. Augmentation pressure was higher in the hypertensive MetS group than in controls and normotensive MetS group (p<0.05). CONCLUSIONS: Pulse wave velocity, an acknowledged marker of arterial stiffness, was associated with MetS even in the absence of hypertension. This emphasizes the importance of the prevention and treatment of MetS.
Authors: Paweł Krzesiński; Adam Stańczyk; Katarzyna Piotrowicz; Grzegorz Gielerak; Beata Uziębło-Zyczkowska; Andrzej Skrobowski Journal: Hypertens Res Date: 2016-01-21 Impact factor: 3.872
Authors: Wanda R P Lopes-Vicente; Sara Rodrigues; Felipe X Cepeda; Camila Paixão Jordão; Valéria Costa-Hong; Akothirene C B Dutra-Marques; Jefferson C Carvalho; Maria Janieire N N Alves; Luiz A Bortolotto; Ivani C Trombetta Journal: Diabetol Metab Syndr Date: 2017-10-25 Impact factor: 3.320
Authors: Pauliina Kangas; Antti Tikkakoski; Jarkko Kettunen; Arttu Eräranta; Heini Huhtala; Mika Kähönen; Kalle Sipilä; Jukka Mustonen; Ilkka Pörsti Journal: Sci Rep Date: 2019-12-05 Impact factor: 4.379
Authors: Rabya Saraf; Thomas Huang; Feroze Mahmood; Khurram Owais; Amit Bardia; Kamal R Khabbaz; David Liu; Venkatachalam Senthilnathan; Antonio D Lassaletta; Frank Sellke; Robina Matyal Journal: PLoS One Date: 2016-01-14 Impact factor: 3.240
Authors: Elena Vega-Martín; Marta Gil-Ortega; Raquel González-Blázquez; Sara Benedito; Jesús Fernández-Felipe; Mariano Ruiz-Gayo; Nuria Del Olmo; Julie A Chowen; Laura M Frago; Beatriz Somoza; María S Fernández-Alfonso Journal: Nutrients Date: 2021-03-19 Impact factor: 5.717